Optic Neuropathy
18
3
3
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
2 terminated out of 18 trials
77.8%
-8.7% vs benchmark
6%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
Building Research With Artificial Intelligence in Neuro-Ophthalmology
Hyperbaric Oxygen Therapy for Optic Neuropathies
Stem Cell Ophthalmology Treatment Study II
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
Clinical Study of FB1001 in Patients
Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus
Use of Bevacizumab in Trabeculectomy Surgery
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient
Effect of Intraocular Tamponade on Visual Perception
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
Biomechanics of Optic Neuropathy
Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
Assessment of Visual Function With a Portable Brain-computer Interface
BIOtinidase Test In Optic-Neuropathy
Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players